NCT06381648View on ClinicalTrials.gov

Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

April 15, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

July 1, 2025

Conditions
CholangiocarcinomaCholangiocarcinoma, IntrahepaticCholangiocarcinoma ResectableCholangiocarcinoma; Liver
Interventions
DIAGNOSTIC_TEST

LyMIC (Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma)

A panel of exosomal miRNAs, whose expression levels are tested in serum or plasma samples collected prior to primary tumor resection, with reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR)

Trial Locations (4)

91016

City of Hope Medical Center, Duarte

060-8648

Department of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University, Hokkaido

812-8582

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka

770-8503

Department of Surgery, Tokushima University, Tokushima

All Listed Sponsors
lead

City of Hope Medical Center

OTHER